BamSEC and AlphaSense Join Forces
Learn More

Biora Therapeutics Inc.

NASDAQ: BIOR    
Share price (12/30/24): $0.22    
Market cap (12/30/24): $995 thousand

Material Contracts Filter

EX-10.1
from 8-K 20 pages Purpose. the Plan, Through the Granting of Awards, Is Intended to Help the Company Secure and Retain the Services of Eligible Award Recipients, Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Any Affiliate and Provide a Means by Which the Eligible Recipients May Benefit From Increases in the Value of the Common Stock. 2. Administration. (A) Administration by Board. the Board Will Administer the Plan. the Board May Delegate Administration of the Plan to a Committee or Committees, as Provided in Section 2(c). (B) Powers of Board. the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan
12/34/56
EX-10.1
from 8-K 46 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 30 pages Biora Therapeutics, Inc. Convertible Notes Exchange Agreement August 12, 2024
12/34/56
EX-10.1
from 8-K 31 pages Biora Therapeutics, Inc. Convertible Notes Purchase Agreement August 12, 2024
12/34/56
EX-10.1
from 8-K 92 pages Securities Purchase Agreement
12/34/56
EX-10.29
from 10-K 38 pages Security Agreement Among Biora Therapeutics, Inc., as Issuer, the Guarantors Party Hereto From Time to Time, as Guarantors and Glas Trust Company LLC as Collateral Agent Dated as of December 19, 2023
12/34/56
EX-10.4
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 24 pages Biora Therapeutics, Inc. Convertible Notes Purchase Agreement March 8, 2024
12/34/56
EX-10.1
from 8-K 18 pages Biora Therapeutics, Inc. Convertible Notes Exchange Agreement for New Notes March 8, 2024
12/34/56
EX-10.4
from 8-K 20 pages Form of Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 36 pages Form of Security Agreement Among Biora Therapeutics, Inc., as Issuer, the Guarantors Party Hereto From Time to Time, as Guarantors and Glas Trust Company LLC as Collateral Agent Dated as of December 19, 2023
12/34/56
EX-10.2
from 8-K 19 pages Biora Therapeutics, Inc. Form of Convertible Notes Purchase Agreement December 18, 2023
12/34/56
EX-10.1
from 8-K 20 pages Biora Therapeutics, Inc. Form of Convertible Notes Exchange Agreement for New Notes and Common Stock or Warrants December 18, 2023
12/34/56
EX-10.2
from 10-Q 17 pages Purchase and Sale Agreement
12/34/56
EX-10.1
from 8-K 21 pages Biora Therapeutics, Inc. Convertible Notes Exchange Agreement for Common Stock and Warrants September 18, 2023
12/34/56
EX-10.1
from 8-K 19 pages Biora Therapeutics, Inc. 2018 Equity Incentive Plan (Fifth Amended & Restated) Adopted by the Board: February 22, 2018 (First Amendment March 6, 2019, Second Amendment December 5, 2019, Third Amendment March 4, 2020, Fourth Amendment May 5, 2021, Fifth Amendment March 22, 2023) Approved by the Stockholders: February 22, 2018
12/34/56
EX-10.2
from 8-K 22 pages Common Stock Purchase Warrant Biora Therapeutics, Inc
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-K 5 pages Restricted Stock Unit Agreement
12/34/56
EX-10
from 10-K 2 pages Biora Therapeutics, Inc. New Hire Employee Notice of Grant of Restricted Stock Units
12/34/56